SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-179555
Filing Date
2013-04-29
Accepted
2013-04-29 06:15:27
Documents
7
Period of Report
2013-06-19
Effectiveness Date
2013-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A d528226ddef14a.htm DEF 14A 669679
2 GRAPHIC g528226g09o10.jpg GRAPHIC 6065
3 GRAPHIC g528226g18p65.jpg GRAPHIC 2022
4 GRAPHIC g528226g40g80.jpg GRAPHIC 1911
5 GRAPHIC g528226g89x45.jpg GRAPHIC 12758
6 GRAPHIC g528226pc1.jpg GRAPHIC 126406
7 GRAPHIC g528226pc2.jpg GRAPHIC 105060
  Complete submission text file 0001193125-13-179555.txt   1021995
Mailing Address 1180 AVENUE OF THE AMERICA 19TH FLOOR NEW YORK NY 10036
Business Address 1180 AVENUE OF THE AMERICA 19TH FLOOR NEW YORK NY 10036 646-214-0700
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33038 | Film No.: 13788995
SIC: 8093 Services-Specialty Outpatient Facilities, NEC